biotech

Science Corporation, a brain-computer interface startup founded by former Neuralink president Max Hodak, has announced a new division focused on extending the viability of human organs for transplantation. The company unveiled a prototype machine designed to preserve organs for longer periods. This initiative expands beyond their core work in neural technology.